(Incorporated in the Cayman Islands)

We are a blank check company focused on small-cap healthcare companies, particularly those involved in the healthcare innovation sector.

Ms. Han Huang, the sole beneficial owner of our sponsor, is a citizen and resident of the People’s Republic of China.

Mr. Heung Ming Wong, our CEO, CFO and a director, is a citizen and resident of the Hong Kong Special Administrative Region.

(Note: Aimee Healthcare Technology Co. II  increased its SPAC IPO’s size to 10 million units – up from 6 million units – and kept the price at $10.00 per unit – to raise $100 million, according to its S-1/A filing on Oct. 26, 2026. Each unit consists of one share and one right to receive three-quarters (3/4th) of a share upon the consummation of its initial business combination. In the S-1/A filing on Oct. 26, 2026, D. Boral Capital was named as the sole book-runner, replacing A.G.P. Background: Aimee Healthcare Technology Co. II filed its S-1 on Dec. 23, 2024, and disclosed the terms: 6 million units at $10.00 each to raise $60 million. Each unit consisted of one share and one right to receive one-seventh (1/7) of a share upon the consummation of its initial business combination. A.G.P. was the sole book-runner.)